<

 
Data updated 2025-05-16 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date15733375.8 (espacenet)  (Federated)  (European Patent Register), 20150617
Patent/reg. no. and dateDK/EP 3157629, 20221005
Publication date20170426
Priority no. and dateUS 201462013157 P, 20140617
EP pub. no. and date EP 3157629 20170426
Effective date
Applicant/ownerMedImmune Limited, Milstein Building
Granta Park
Cambridge
CB21 6GH, GB
Applicant ref. no.1529348
InventorDOVEDI, Simon, University of Manchester
Oxford Road
Manchester M13 9PL, GB,
ILLIDGE, Tim, University of Manchester
Oxford Road
Manchester M13 9PL, GB,
STEWART, Ross, MedImmune Limited Milstein Building
Cambridge
Cambridgeshire Granta Park, GB,
MORROW, Michelle, MedImmune Limited Milstein Building
Cambridge
Cambridgeshire Granta Park, GB,
WILKINSON, Robert, MedImmune Limited Milstein Building
Cambridge
Cambridgeshire Granta Park, GB,
POON, Edmund, MedImmune Limited Milstein Building
Cambridge
Cambridgeshire Granta Park, GB
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB, GB
Opponent
IPC ClassA61K 39/395 (2006.01) , A61N 5/10 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) 
TitleFREMGANGSMÅDER TIL CANCERBEHANDLING MED ANTAGONISTER MOD PD-1 OG PD-L1 I KOMBINATION MED STRÅLEBEHANDLING
Int. application no.EP2015063552
Int. publication no.WO2015193352
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact